UBS Group »

Anika Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $271k 29k 9.40
2025-06-30 $964k 91k 10.58
2025-03-31 $211k 14k 15.03
2024-12-31 $1.1M 69k 16.46
2024-09-30 $186k 7.5k 24.70
2024-06-30 $180k 7.1k 25.33
2024-03-31 $476k 19k 25.40
2023-12-31 $348k 15k 22.66
2023-09-30 $175k 9.4k 18.63
2023-06-30 $606k 23k 25.98
2023-03-31 $573k 20k 28.72
2022-12-31 $737k 25k 29.60
2022-09-30 $135k 5.8k 23.33
2022-06-30 $110k 5.0k 22.25
2022-03-31 $778k 29k 26.67
2021-12-31 $1.0M 30k 35.25
2021-09-30 $865k 20k 42.34
2021-06-30 $443k 10k 43.80
2021-03-31 $798k 20k 40.79
2020-12-31 $45k 986 45.64
2020-09-30 $75k 2.1k 35.27
2020-06-30 $44k 1.2k 37.45
2020-03-31 $200k 6.9k 28.88
2019-12-31 $195k 3.8k 51.86
2019-09-30 $2.0M 37k 54.88
2019-06-30 $749k 18k 40.78
2019-03-31 $3.3M 109k 30.19
2018-12-31 $2.4M 72k 33.60
2018-09-30 $2.7M 63k 42.21
2018-06-30 $1.7M 52k 32.00
2018-03-31 $154k 3.1k 49.79
2017-12-31 $255k 4.8k 53.61
2017-09-30 $148k 2.6k 57.73
2017-06-30 $89k 1.8k 49.06
2017-03-31 $75k 1.7k 43.58
2016-12-31 $146k 3.0k 49.21
2016-09-30 $142k 3.0k 47.79
2016-06-30 $108k 2.0k 52.50
2016-03-31 $749k 17k 45.00
2015-12-31 $63k 1.7k 37.83
2015-09-30 $82k 2.5k 32.35
2015-03-31 $612k 16k 39.22